Tag: Novavax

How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year

Novavax (NVAX), the latest company to enter the increasingly crowded field to produce a coronavirus vaccine, is juggling multiple pieces in order to meet an aggressive development timeline, CEO Stanley Erck explained to Yahoo Finance on Thursday.

This week, the biotech company entered into clinical trials in Australia, making it one of a dozen companies to do so out of more than 100 existing vaccine candidates. Like other drug candidates, Novavax’s experimental treatment is being produced at risk in order to meet unprecedented demand, with the COVID-19 crisis sickening nearly 6 million worldwide, and killing over 350,000.

Experts say the

Read more